A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: A multicenter evaluation

International Journal of Gynecological Cancer

Volumn 13, Issue 6, 2003, Pages 804-811

  Singer, Albert ^a   Coppleson, M ^b   Canfell, K ^c   Skladnev, V ^c   Mackellar, G ^c   Pisal, N ^a   Deery, A ^d  

^a WHITTINGTON HOSPITAL   (United Kingdom)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Polartechnics Limited   (Australia)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cervical screening; Optoelectronic device; Real time screening

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; DEVICE; DIAGNOSTIC ACCURACY; FEMALE; GYNECOLOGIC CANCER; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPTOELECTRONIC DEVICE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; AUTOMATION; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; ELECTRIC STIMULATION; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; OPTICS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 1242272004     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2003.13393.x     Document Type: Article

References (15)

1. Quinn M, Babb P, Jones J, Allen E, on behalf of the United Kingdom Association of Cancer Registries. Effect of screening on incidence of and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics. BMJ 1999;318:904-8.
2. McCrory DC, Mather DB, Bastian L et al. Evaluation of cervical cytology. Evidence Report/Technology Assessment No. 5 (Prepared by Dule University under Contract No. 290-97-0014). AHCPR Publication No. 99-E010. Rockville, MD. USA: Agency for Health Care Policy and Research. February 1999.
3. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000;88:2283-9.
4. Coppleson M, Canfell K, Skladnev V. The Polarprobe - An instantaneous optoelectronic approach to cervical screening. CME J Gynecol Oncol 2000;5:31-8.
5. Coppleson M, Reid BL, Skladnev VN, Dalrymple JC. An electronic approach to the detection of pre-cancer and cancer of the uterine cervix: a preliminary evaluation of Polarprobe. Int J Gynecol Cancer 1994;4:79-83.
6. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
7. NHS Cervical Screening Program. Resource pack for training smear takers. Publication no. 9, 1998.
8. Commonwealth of Australia Department of Health and Family Services. Screening for the prevention of cervical cancer. Publication no. 1031, 1998.
9. Denny L, Kuhn L, Pollack A, Wright TC Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94: 1699-707.
10. Boyko EJ. Meta-analysis of Pap test accuracy. Am J Epidemiol 1996;143:406-7.
11. Ismail SM, Colclough AB, Dinnen JS et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989;298: 707-10.
12. Robertson AJ, Anderson JM, Beck JS et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989;42:231-8.
13. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ for the 2001 ASCCP-Sponsored Consensus Conference. 2001. Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
14. UK Department of Health. Report of the Cervical Screening Program, Bulletin 2001/22, September, 2001.
15. Broadstock M. Liquid-based cytology - an alternative international view. Cytopathology 2001;12:141-3.